China Pharma Announces the Entry of "At-The-Market" Equity Offering

China Pharma Announces the Entry of "At-The-Market" Equity Offering

HAIKOU, China, Dec. 13, 2024 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," or the "Company"), a specialty pharmaceutical company, today announced that it has filed a prospectus supplement with the U.S. Securities...

Update of "JPxData Portal (beta version)," a free data portal site for searching various securities data, issue information and disclosure information for individual/corporate users

Update of "JPxData Portal (beta version)," a free data portal site for searching various securities data, issue information and disclosure information for individual/corporate users

TOKYO, Dec. 12, 2024 /PRNewswire/ -- The JPX Market Innovation & Research, Inc., a group company of Japan Exchange Group, Inc. (JPX), began provision of "JPxData Portal (beta version)" (hereinafter referred to as "the Portal"), a data portal to...

DID YOU HAVE A HIP, KNEE, OR OTHER JOINT REPLACEMENT?

DID YOU HAVE A HIP, KNEE, OR OTHER JOINT REPLACEMENT?

If your implant/replacement involved Exactech products – including Optetrak, Optetrak Logic, Truliant, Vantage, Connexion GXL, and Equinoxe – your attention to this notice is important. NEW YORK, Dec. 12, 2024 /PRNewswire/ -- The following is being...

MMTEC, Inc. Announces 1-for-8 Reverse Stock Split

MMTEC, Inc. Announces 1-for-8 Reverse Stock Split

HONG KONG, Dec. 12, 2024 /PRNewswire/ -- MMTEC, Inc. ("MMTEC" or the "Company") (Nasdaq: MTC) reported that it expects to implement a 1-for-8 reverse stock split on its common stock. The effective date is scheduled to be December 18, 2024, subject...

GATE Energy Awarded Sparta Commissioning Contract

GATE Energy Awarded Sparta Commissioning Contract

HOUSTON, Dec. 10, 2024 /PRNewswire/ -- GATE Energy is pleased to announce it has been awarded the commissioning management and execution contract from Shell Offshore, Inc. for the Sparta semi-submersible project. With capabilities spanning owner's...

SS&C Signs Agreement with Insignia Financial

SS&C Signs Agreement with Insignia Financial

WINDSOR, Conn., Dec. 10, 2024 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced an initial agreement with Insignia Financial (Insignia) to deliver superannuation member administration services. Insignia Financial...

New Vectorworks Report Highlights AI, VR, and Sustainability Trends Shaping the Future of Event Design and Production

New Vectorworks Report Highlights AI, VR, and Sustainability Trends Shaping the Future of Event Design and Production

In Collaboration with Entourage Pro, the Insights Tech Report Reveals the State of Technology Adoption Amid Ongoing Cost, Ethical, and Education Challenges. COLUMBIA, Md., Dec. 10, 2024 /PRNewswire/ -- Global design and BIM software provider...

2024 ESMO Asia: TransThera announces clinical data of tinengotinib in combination with atezolizumab (PD-L1) in biliary tract carcinoma (BTC)

2024 ESMO Asia: TransThera announces clinical data of tinengotinib in combination with atezolizumab (PD-L1) in biliary tract carcinoma (BTC)

NANJING, China and GAITHERSBURG, Md., Dec. 9, 2024 /PRNewswire/ -- TransThera Sciences Nanjing, Inc. (the "TransThera") announced the poster presentation at the 2024 European Society For Medical Oncology (ESMO) Asia Congress to discuss the clinical...

QNAP Announces Short-Depth Rackmount NAS TS-433eU with NPU Acceleration and Dual 2.5GbE

QNAP Announces Short-Depth Rackmount NAS TS-433eU with NPU Acceleration and Dual 2.5GbE

TAIPEI, Dec. 9, 2024 /PRNewswire/ -- QNAP® Systems, Inc., a leading computing and storage solutions innovator, today unveiled the compact 1U rackmount 4-bay NAS TS-433eU, which offers small to midsize businesses and organizations an affordable edge...

Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024

Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024

SAN FRANCISCO and SUZHOU, China, Dec. 9, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 14
  • menu
    menu